Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 34 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

New procedure codes to be introduced in CCAM Nomenclature published in France

24 Mar 2023

On March 2, 2023, the decision of the National Union of Health Insurance Funds relating to the update of the CCAM Nomenclature of procedure codes was published in the Official Journal of the French Republic. Changes include registration of new procedure codes, modification and removal of some existing codes. Newly introduced codes concern cardiovascular procedures, interventional radiology, orthopedics, peripheral vascular procedures, and others.

The examples of newly introduced codes are listed below:

  • DDNF775 “Intraluminal lithotripsy of the coronary artery with coronary arteriography, with stenting, by transcutaneous arterial route” with the CCAM fee of €983.93;
  • EDSF618 “Hyperselective embolization of the prostatic arteries, by transcutaneous arterial route” with the CCAM fee of €543.74;
  • LDKA426 “Replacement of a cervical intervertebral disc by total prosthesis, by cervicotomy” with the CCAM fee of €638.10.

The decision takes effect on April 1, 2023, and the newly introduced codes are present in v72 of the CCAM  Nomenclature.

See the details in French here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.